Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ikbkbem1flox/Cya
Common Name:
Ikbkb-flox
Product ID:
S-CKO-03072
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ikbkb-flox
Strain ID
CKOCMP-16150-Ikbkb-B6J-VA
Gene Name
Ikbkb
Product ID
S-CKO-03072
Gene Alias
IKK-2; IKK-B; IKK-beta; IKK2; IKK[b]; IKKbeta; NFKBIKB
Background
C57BL/6JCya
NCBI ID
16150
Modification
Conditional knockout
Chromosome
8
Phenotype
MGI:1338071
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ikbkbem1flox/Cya mice (Catalog S-CKO-03072) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000063401
NCBI RefSeq
NM_010546
Target Region
Exon 4
Size of Effective Region
~1.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ikbkb, also known as IKKβ (IkappaB kinase beta) or IKK2, is a key molecule in the signaling pathway to the transcription factor NF-κB. Its kinase activity phosphorylates IkappaB molecules, leading to their ubiquitination and proteasomal degradation, and subsequent release and activation of NF-κB. Many signaling pathways that activate NF-κB converge at the level of Ikbkb. NF-κB has diverse functions in regulating the immune system, cellular differentiation, survival, and proliferation. Ikbkb is thus crucial in acute and chronic inflammation, which is associated with various diseases, and also in cancer where NF-κB can act as a survival factor for malignant cells [7].

In Huntington's disease, Ikbkb can regulate endogenous S13 huntingtin phosphorylation via a non-canonical interferon regulatory factor3-mediated IKK pathway, reducing mutant huntingtin aggregation [1]. In a male infant with a heterozygous gain-of-function (GOF) Ikbkb variant, it was associated with autoimmunity and autoinflammation, showing increased basal levels of phosphorylation of IKKα/β and p65, and higher degradation of IkBα in transduced Jurkat cells [2]. In spinal nerve ligation (SNL) rats, delivering Ikbkb small interfering RNA (siRNA)-encapsulated poly (lactic-co-glycolic acid) (PLGA) nanoparticles reduced neuropathic pain by inhibiting microglial activation [3]. In clear cell renal cell carcinoma (ccRCC), decreased Ikbkb expression was observed, and patients with upregulated Ikbkb protein expression had higher nuclear grade tumors and shorter survival [4]. In hepatocellular carcinoma (HCC), IKKβ phosphorylated and stabilized USP30, promoting lipogenesis and tumorigenesis [5]. In gliomagenesis, α-ketoglutarate-produced by GDH1 under low glucose-directly binds to and activates IKKβ and NF-κB signaling, promoting glucose uptake and tumor cell survival [6]. In osteoarthritis, decreased miR-214-3p activates the NF-κB signaling pathway and aggravates OA development through targeting Ikbkb [8].

In conclusion, Ikbkb is essential in the NF-κB signaling pathway and has a significant impact on various biological processes and disease conditions such as neurodegenerative diseases, autoimmune and autoinflammatory disorders, neuropathic pain, cancer, and osteoarthritis. Studies on Ikbkb, especially through functional models, help in understanding disease mechanisms and may provide potential therapeutic targets.

References:
1. Cariulo, Cristina, Martufi, Paola, Verani, Margherita, Petricca, Lara, Caricasole, Andrea. 2023. IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathway. In Life science alliance, 6, . doi:10.26508/lsa.202302006. https://pubmed.ncbi.nlm.nih.gov/37553253/
2. Sacco, Keith, Kuehn, Hye Sun, Kawai, Tomoki, Rosenzweig, Sergio D, Keller, Michael D. 2022. A Heterozygous Gain-of-Function Variant in IKBKB Associated with Autoimmunity and Autoinflammation. In Journal of clinical immunology, 43, 512-520. doi:10.1007/s10875-022-01395-2. https://pubmed.ncbi.nlm.nih.gov/36378426/
3. Lee, Seounghun, Shin, Hyo-Jung, Noh, Chan, Lee, Won-Hyung, Kim, Yoon-Hee. 2021. IKBKB siRNA-Encapsulated Poly (Lactic-co-Glycolic Acid) Nanoparticles Diminish Neuropathic Pain by Inhibiting Microglial Activation. In International journal of molecular sciences, 22, . doi:10.3390/ijms22115657. https://pubmed.ncbi.nlm.nih.gov/34073390/
4. Krazinski, Bartlomiej E, Kowalczyk, Anna E, Sliwinska-Jewsiewicka, Agnieszka, Kmiec, Zbigniew, Kiewisz, Jolanta. 2018. IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes. In Oncology reports, 41, 1189-1197. doi:10.3892/or.2018.6872. https://pubmed.ncbi.nlm.nih.gov/30483769/
5. Gu, Li, Zhu, Yahui, Lin, Xi, Prochownik, Edward V, Li, Youjun. 2020. The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis. In Hepatology (Baltimore, Md.), 73, 160-174. doi:10.1002/hep.31249. https://pubmed.ncbi.nlm.nih.gov/32221968/
6. Wang, Xiongjun, Liu, Ruilong, Qu, Xiujuan, Li, Guohui, Yang, Weiwei. 2019. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development. In Molecular cell, 76, 148-162.e7. doi:10.1016/j.molcel.2019.07.007. https://pubmed.ncbi.nlm.nih.gov/31447391/
7. Schmid, Johannes A, Birbach, Andreas. 2008. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB. In Cytokine & growth factor reviews, 19, 157-65. doi:10.1016/j.cytogfr.2008.01.006. https://pubmed.ncbi.nlm.nih.gov/18308615/
8. Cao, Yumei, Tang, Su'an, Nie, Xiaoyu, Zhu, Zhaohua, Ding, Changhai. 2021. Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression. In EBioMedicine, 65, 103283. doi:10.1016/j.ebiom.2021.103283. https://pubmed.ncbi.nlm.nih.gov/33714889/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest